ImmuCell (ICCC) Short Interest Ratio & Short Volume $6.39 -0.23 (-3.47%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$6.58 +0.19 (+2.91%) As of 07/2/2025 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ImmuCell Short Interest DataImmuCell (ICCC) has a short interest of 7,300 shares, representing 0.13% of the float (the number of shares available for trading by the public). This marks a 28.07% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 24,969 shares to cover all short positions.Current Short Interest7,300 sharesPrevious Short Interest5,700 sharesChange Vs. Previous Month+28.07%Dollar Volume Sold Short$47.30 thousandShort Interest Ratio0.2 Days to CoverLast Record DateJune 15, 2025Outstanding Shares9,040,000 sharesFloat Size5,820,000 sharesShort Percent of Float0.13%Today's Trading Volume3,325 sharesAverage Trading Volume24,969 sharesToday's Volume Vs. Average13% Short Selling ImmuCell? Sign up to receive the latest short interest report for ImmuCell and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartICCC Short Interest Over TimeICCC Days to Cover Over TimeICCC Percentage of Float Shorted Over Time ImmuCell Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20257,300 shares $47.30 thousand +28.1%0.1%0.2 $6.48 5/31/20255,700 shares $36.14 thousand -51.3%0.1%0.2 $6.34 5/15/202511,700 shares $62.01 thousand +82.8%0.2%0.5 $5.30 4/30/20256,400 shares $34.69 thousand +42.2%0.1%0.4 $5.42 4/15/20254,500 shares $24.26 thousand -65.9%0.1%0.3 $5.39 3/31/202513,200 shares $63.23 thousand No Change0.2%1.3 $4.79 3/15/202513,200 shares $65.87 thousand -22.8%0.2%1.7 $4.99 2/28/202517,100 shares $90.29 thousand -6.6%0.3%1.7 $5.28 2/15/202518,300 shares $92.42 thousand +18.1%0.3%1.5 $5.05 1/31/202515,500 shares $83.55 thousand -1.9%0.3%1.2 $5.39 Get the Latest News and Ratings for ICCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmuCell and its competitors with MarketBeat's FREE daily newsletter. 1/15/202515,800 shares $83.58 thousand -3.7%0.3%1 $5.29 12/31/202416,400 shares $84.46 thousand +24.2%0.3%0.9 $5.15 12/15/202413,200 shares $64.94 thousand -14.8%0.2%0.7 $4.92 11/30/202415,500 shares $63.86 thousand -34.3%0.3%0.7 $4.12 11/15/202423,600 shares $85.20 thousand +490.0%0.4%0.7 $3.61 10/31/20244,000 shares $14.44 thousand -51.2%0.1%0.1 $3.61 10/15/20248,200 shares $29.11 thousand -29.9%0.2%0.2 $3.55 9/30/202411,700 shares $42.47 thousand +37.7%0.3%0.3 $3.63 9/15/20248,500 shares $30.86 thousand -54.3%0.2%0.2 $3.63 8/31/202418,600 shares $69.56 thousand +644.0%0.4%0.6 $3.74 8/15/20242,500 shares $9.23 thousand -40.5%0.0%0.1 $3.69 7/31/20244,200 shares $17.05 thousand +5.0%0.1%0.4 $4.06 7/15/20244,000 shares $16.96 thousand -29.8%0.1%0.4 $4.24 6/30/20245,700 shares $27.65 thousand -12.3%0.1%0.5 $4.85 6/15/20246,500 shares $27.17 thousand +30.0%0.1%0.5 $4.18 5/31/20245,000 shares $21.25 thousand +66.7%0.1%0.4 $4.25 5/15/20243,000 shares $14.64 thousand -41.2%0.1%0.3 $4.88 4/30/20245,100 shares $25.04 thousand +13.3%0.1%0.6 $4.91 4/15/20244,500 shares $22.73 thousand -26.2%0.1%0.6 $5.05 3/31/20246,100 shares $32.33 thousand -4.7%0.1%0.8 $5.30 3/15/20246,400 shares $33.60 thousand +1.6%0.1%0.8 $5.25 2/29/20246,300 shares $33.08 thousand -20.3%0.1%0.8 $5.25 2/15/20247,900 shares $39.70 thousand +5.3%0.1%0.9 $5.03 1/31/20247,500 shares $39.83 thousand -2.6%0.1%0.8 $5.31 1/15/20247,700 shares $39.35 thousand -13.5%0.1%0.6 $5.11 12/31/20238,900 shares $45.30 thousand +30.9%0.2%0.8 $5.09 12/15/20236,800 shares $31.14 thousand +13.3%0.1%0.5 $4.58 11/30/20236,000 shares $27.24 thousand -7.7%0.1%0.4 $4.54 11/15/20236,500 shares $32.83 thousand -52.2%0.1%0.4 $5.05 10/31/202313,600 shares $68.68 thousand +70.0%0.3%0.8 $5.05I was wrong about Trump (Ad)I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.Let me show you exactly what we’re doing to prepare. 10/15/20238,000 shares $40.16 thousand -28.6%0.1%0.5 $5.02 9/30/202311,200 shares $59.81 thousand +62.3%0.2%0.7 $5.34 9/15/20236,900 shares $36.98 thousand +15.0%0.1%0.4 $5.36 8/31/20236,000 shares $27.66 thousand No Change0.1%0.4 $4.61 8/15/20236,000 shares $29.70 thousand -11.8%0.1%0.5 $4.95 7/31/20236,800 shares $36.92 thousand +11.5%0.1%0.6 $5.43 7/15/20236,100 shares $31.05 thousand -3.2%0.1%0.6 $5.09 6/30/20236,300 shares $31.50 thousand No Change0.1%0.7 $5.00 6/15/20236,300 shares $34.71 thousand -6.0%0.1%0.8 $5.51 5/31/20236,700 shares $31.96 thousand -30.2%0.1%0.8 $4.77 5/15/20239,600 shares $47.71 thousand No Change0.2%1.1 $4.97 10/31/202210,500 shares $84.11 thousand -38.2%0.2%1.3 $8.01 10/15/202217,000 shares $133.62 thousand +60.4%0.3%2 $7.86 9/30/202210,600 shares $79.29 thousand +6.0%0.2%1.2 $7.48 9/15/202210,000 shares $75.70 thousand +19.1%0.2%1.1 $7.57 8/31/20228,400 shares $61.24 thousand +12.0%0.2%0.9 $7.29 8/15/20227,500 shares $60.45 thousand -24.2%0.1%1 $8.06 7/31/20229,900 shares $86.92 thousand +32.0%0.2%1.1 $8.78 7/15/20227,500 shares $63 thousand -13.8%0.1%0.7 $8.40 6/30/20228,700 shares $75.60 thousand +24.3%0.2%0.8 $8.69 6/15/20227,000 shares $56.84 thousand +1.5%0.1%0.6 $8.12 5/31/20226,900 shares $55.96 thousand No Change0.1%0.6 $8.11 5/15/20226,900 shares $55.96 thousand -45.2%0.1%0.6 $8.11 4/30/202212,600 shares $122.72 thousand +41.6%0.2%1.1 $9.74 4/15/20228,900 shares $79.66 thousand -22.6%0.2%0.8 $8.95 3/31/202211,500 shares $110.98 thousand +21.1%N/A1.1 $9.65 3/15/20229,500 shares $82.27 thousand +50.8%0.2%0.9 $8.66 2/28/20226,300 shares $51.47 thousand -24.1%0.1%0.6 $8.17 2/15/20228,300 shares $68.23 thousand +38.3%0.2%0.7 $8.22 1/31/20226,000 shares $48.90 thousand -31.0%0.1%0.5 $8.15 1/15/20228,700 shares $76.62 thousand +11.5%N/A0 $8.81 12/31/20217,800 shares $62.40 thousand +39.3%0.1%1 $8.00 12/15/20215,600 shares $47.82 thousand -35.6%0.1%0.8 $8.54 11/30/20218,700 shares $77.69 thousand +13.0%0.2%1.5 $8.93 11/15/20217,700 shares $70.84 thousand -10.5%0.1%1.2 $9.20 10/29/20218,600 shares $75.68 thousand +24.6%0.2%1.1 $8.80 10/15/20216,900 shares $64.03 thousand -33.7%0.1%0.9 $9.28 9/30/202110,400 shares $97.34 thousand -3.7%0.2%0.8 $9.36 9/15/202110,800 shares $99.25 thousand -12.9%0.2%0.8 $9.19 8/31/202112,400 shares $113.58 thousand -29.1%0.2%0.9 $9.16 8/13/202117,500 shares $157.68 thousand +7.4%0.3%1.4 $9.01 7/30/202116,300 shares $164.14 thousand +109.0%0.3%1.1 $10.07 7/15/20217,800 shares $70.20 thousand -25.7%0.1%0.5 $9.00 6/30/202110,500 shares $99.75 thousand +15.4%0.2%0.8 $9.50 6/15/20219,100 shares $89.55 thousand -37.7%0.2%0.7 $9.84 5/28/202114,600 shares $142.64 thousand +31.5%0.3%1 $9.77 5/14/202111,100 shares $102.23 thousand -11.9%0.2%0.6 $9.21 4/30/202112,600 shares $128.65 thousand +46.5%0.2%0.5 $10.21 4/15/20218,600 shares $79.64 thousand +28.4%N/A0 $9.26 3/31/20216,700 shares $62.65 thousand +19.6%0.1%0.1 $9.35I was wrong about Trump (Ad)I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.Let me show you exactly what we’re doing to prepare. 3/15/20215,600 shares $60.31 thousand -5.1%0.1%0.1 $10.77 2/26/20215,900 shares $62.78 thousand -10.6%0.1%0.1 $10.64 2/12/20216,600 shares $74.38 thousand -14.3%0.1%0.1 $11.27 1/29/20217,700 shares $57.37 thousand +63.8%0.2%0.2 $7.45 1/15/20214,700 shares $29.59 thousand +14.6%0.1%0.4 $6.30 12/31/20204,100 shares $24.56 thousand -28.1%0.1%0.4 $5.99 12/15/20205,700 shares $36.42 thousand +67.7%0.1%0.7 $6.39 11/30/20203,400 shares $20.40 thousand -5.6%0.1%0.4 $6.00 11/15/20203,600 shares $20.70 thousand +50.0%0.1%0.4 $5.75 10/30/20202,400 shares $12.50 thousand -74.5%0.1%0.3 $5.21 10/15/20209,400 shares $52.83 thousand -42.0%0.2%0.9 $5.62 9/30/202016,200 shares $87.97 thousand -3.6%0.3%1.4 $5.43 9/15/202016,800 shares $88.03 thousand +162.5%0.3%1 $5.24 8/31/20206,400 shares $33.41 thousand -46.2%0.1%0.3 $5.22 8/14/202011,900 shares $66.88 thousand -56.7%0.2%0.5 $5.62 7/31/202027,500 shares $136.95 thousand +32.9%0.5%0.9 $4.98 7/15/202020,700 shares $125.24 thousand +38.9%0.4%0.7 $6.05 ICCC Short Interest - Frequently Asked Questions What is ImmuCell's current short interest? Short interest is the volume of ImmuCell shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 7,300 shares of ICCC short. 0.13% of ImmuCell's shares are currently sold short. Learn More on ImmuCell's current short interest. What is a good short interest percentage for ImmuCell? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.13% of ImmuCell's floating shares are currently sold short. Is ImmuCell's short interest increasing or decreasing? ImmuCell saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 7,300 shares, an increase of 28.1% from the previous total of 5,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ImmuCell's float size? ImmuCell currently has issued a total of 9,040,000 shares. Some of ImmuCell's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ImmuCell currently has a public float of 5,820,000 shares. How does ImmuCell's short interest compare to its competitors? 0.13% of ImmuCell's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ImmuCell: ADC Therapeutics SA (4.83%), Entrada Therapeutics, Inc. (4.95%), Corvus Pharmaceuticals, Inc. (16.29%), Allogene Therapeutics, Inc. (13.72%), Sagimet Biosciences Inc. (16.13%), 2seventy bio, Inc. (5.37%), Cidara Therapeutics, Inc. (8.45%), Foghorn Therapeutics Inc. (5.27%), Annexon, Inc. (10.47%), Amarin Corporation PLC (2.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short ImmuCell stock? Short selling ICCC is an investing strategy that aims to generate trading profit from ImmuCell as its price is falling. ICCC shares are trading down $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ImmuCell? A short squeeze for ImmuCell occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ICCC, which in turn drives the price of the stock up even further. How often is ImmuCell's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ICCC, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies ADCT Short Squeeze TRDA Short Squeeze CRVS Short Squeeze ALLO Short Squeeze SGMT Short Squeeze TSVT Short Squeeze CDTX Short Squeeze FHTX Short Squeeze ANNX Short Squeeze AMRN Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ICCC) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmuCell Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmuCell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
